SEO URLwww.firestrike.ai/deals/surf-bio-halozyme-therapeutics-acquisition-2026
acquisitionAnnounced · Jan 28, 2026biopharmaceuticalSource · SpeculativeArticle · Factual
Halozyme Therapeutics acquires Surf Bio
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$400M
Target
Surf Bio
Palo Alto, California
Acquirer
Halozyme Therapeutics
Full Acquisition
Status
Completed
Halozyme Therapeutics agreed to acquire Surf Bio. Reported deal value: $400M. Status: Completed. Sector: biopharmaceutical. Target headquarters context: Palo Alto, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-28. Figures and status may change as filings and press coverage update.
Halozyme on Wednesday also said that it acquired Surf Bio for up to $ 400 million in December to expand its drug delivery opportunity
Deal timeline
Announced
Jan 28, 2026 · newsable.asianetnews.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biopharmaceutical with a reported deal value of $400M. Figures and status may change as sources update.
Sources: newsable.asianetnews.com · Primary article · FireStrike proprietary index